1996
DOI: 10.1097/00004872-199612000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Insulin sensitivity following treatment with the ??1-blocker bunazosin retard and the ??1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Glucose uptake was calculated at steady-state during the final 40 min of the clamp (80 -120 min) on the basis of the amount of glucose infused. It was divided by the steady-state plasma glucose concentration to correct for differences in the acquired glucose levels [20], which obviously were different in the two centres according to the protocols used. Thus, the metabolic clearance rate of glucose (MCR) was obtained, and MCR was expressed per lean body mass, LBM, in order to adjust for different degrees of adiposity.…”
Section: Euglycaemic Hyperinsulinaemic Clampmentioning
confidence: 99%
“…Glucose uptake was calculated at steady-state during the final 40 min of the clamp (80 -120 min) on the basis of the amount of glucose infused. It was divided by the steady-state plasma glucose concentration to correct for differences in the acquired glucose levels [20], which obviously were different in the two centres according to the protocols used. Thus, the metabolic clearance rate of glucose (MCR) was obtained, and MCR was expressed per lean body mass, LBM, in order to adjust for different degrees of adiposity.…”
Section: Euglycaemic Hyperinsulinaemic Clampmentioning
confidence: 99%
“…The M-value was calculated by dividing the glucose infusion rate by body weight (mg/kg/min). Insulin sensitivity index (ISI) is a measure of tissue sensitivity to insulin adjusted for the prevailing insulin level, and was calculated by dividing the M-value by the mean insulin concentration during the same period of the clamp (100 mg/kg/min/ (mU/l) [30,31]. The metabolic clearance rate for insulin (MCR ins ) was calculated at steady state by dividing insulin infusion rate with the mean serum insulin level measured at 60, 90 and 120 min (ml/kg/min) [32].…”
Section: Patientsmentioning
confidence: 99%
“…Some of the widely used antihypertensive agents have been demonstrated to modify insulin sensitivity and also alter the atherogenic risk profiles. β-Adrenoceptor blockers and thiazides decrease insulin sensitivity and worsen dyslipidemia (9)(10)(11)(12), and angiotensin-converting enzyme (ACE) inRecently, cilnidipine, a long acting Ca-channel antagonist that blocks both L-and N-type Ca 2 -channels, has become available in Japan. The N-type Ca 2 -channel exists specifically in neural cells.…”
Section: Introductionmentioning
confidence: 99%